83 related articles for article (PubMed ID: 2478718)
1. Impact of the genetic background of transgenic mice upon the formation and timing of choroid plexus papillomas.
Cho HJ; Seiberg M; Georgoff I; Teresky AK; Marks JR; Levine AJ
J Neurosci Res; 1989 Sep; 24(1):115-22. PubMed ID: 2478718
[TBL] [Abstract][Full Text] [Related]
2. The expression of viral and cellular genes in papillomas of the choroid plexus induced in transgenic mice.
Marks J; Lin J; Miller D; Lozano G; Herbert J; Levine AJ
Prog Clin Biol Res; 1988; 284():163-86. PubMed ID: 2851142
[TBL] [Abstract][Full Text] [Related]
3. Developmental study of SV40 large T antigen expression in transgenic mice with choroid plexus neoplasia.
Messing A; Pinkert CA; Palmiter RD; Brinster RL
Oncogene Res; 1988; 3(1):87-97. PubMed ID: 3060799
[TBL] [Abstract][Full Text] [Related]
4. Cellular gene expression in papillomas of the choroid plexus from transgenic mice that express the simian virus 40 large T antigen.
Marks JR; Lin J; Hinds P; Miller D; Levine AJ
J Virol; 1989 Feb; 63(2):790-7. PubMed ID: 2642978
[TBL] [Abstract][Full Text] [Related]
5. SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice.
Palmiter RD; Chen HY; Messing A; Brinster RL
Nature; 1985 Aug 1-7; 316(6027):457-60. PubMed ID: 2991771
[TBL] [Abstract][Full Text] [Related]
6. Relationship between simian virus 40 large tumor antigen expression and tumor formation in transgenic mice.
Van Dyke TA; Finlay C; Miller D; Marks J; Lozano G; Levine AJ
J Virol; 1987 Jun; 61(6):2029-32. PubMed ID: 3033329
[TBL] [Abstract][Full Text] [Related]
7. Renin-promoter SV40 large T-antigen transgenes induce tumors irrespective of normal cellular expression of renin genes.
Sola C; Tronik D; Dreyfus M; Babinet C; Rougeon F
Oncogene Res; 1989; 5(2):149-53. PubMed ID: 2558335
[TBL] [Abstract][Full Text] [Related]
8. SV40 T-antigen induces breast cancer formation with a high efficiency in lactating and virgin WAP-SV-T transgenic animals but with a low efficiency in ovariectomized animals.
Santarelli R; Tzeng YJ; Zimmermann C; Guhl E; Graessmann A
Oncogene; 1996 Feb; 12(3):495-505. PubMed ID: 8637705
[TBL] [Abstract][Full Text] [Related]
9. Developmental analysis of bone tumors in polyomavirus transgenic mice.
Wang R; Siegal GP; Scott DL; Bautch VL
Lab Invest; 1994 Jan; 70(1):86-94. PubMed ID: 8302023
[TBL] [Abstract][Full Text] [Related]
10. Transgenic mice bearing the polyomavirus large T antigen directed by 2.1 kb of the keratin 19 promoter develop bronchiolar papillary tumors with progression to lung adenocarcinomas.
Lebel M; Webster M; Muller WJ; Royal A; Gauthier J; Mes-Masson AM
Cell Growth Differ; 1995 Dec; 6(12):1591-600. PubMed ID: 9019164
[TBL] [Abstract][Full Text] [Related]
11. Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human alpha-1-antitrypsin gene.
Sepulveda AR; Finegold MJ; Smith B; Slagle BL; DeMayo JL; Shen RF; Woo SL; Butel JS
Cancer Res; 1989 Nov; 49(21):6108-17. PubMed ID: 2551499
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
[TBL] [Abstract][Full Text] [Related]
13. Tumorigenesis in transgenic mice by a nuclear transport-defective SV40 large T-antigen gene.
Pinkert CA; Brinster RL; Palmiter RD; Wong C; Butel JS
Virology; 1987 Sep; 160(1):169-75. PubMed ID: 2820126
[TBL] [Abstract][Full Text] [Related]
14. Tumorigenesis and eye abnormalities in transgenic mice expressing MSV-SV40 large T-antigen.
Theuring F; Götz W; Balling R; Korf HW; Schulze F; Herken R; Gruss P
Oncogene; 1990 Feb; 5(2):225-32. PubMed ID: 2157185
[TBL] [Abstract][Full Text] [Related]
15. Differentiation and oncogenesis: phenotypically distinct lens tumors in transgenic mice.
Nakamura T; Mahon KA; Miskin R; Dey A; Kuwabara T; Westphal H
New Biol; 1989 Nov; 1(2):193-204. PubMed ID: 2562221
[TBL] [Abstract][Full Text] [Related]
16. Progressive and regressive fate of lens tumors correlates with subtle differences in transgene expression in gamma F-crystallin-SV40 T antigen transgenic mice.
Bryce DM; Liu Q; Khoo W; Tsui LC; Breitman ML
Oncogene; 1993 Jun; 8(6):1611-20. PubMed ID: 8389033
[TBL] [Abstract][Full Text] [Related]
17. Mouse transgenic for murine oviduct-specific glycoprotein promoter-driven simian virus 40 large T-antigen: tumor formation and its hormonal regulation.
Miyoshi I; Takahashi K; Kon Y; Okamura T; Mototani Y; Araki Y; Kasai N
Mol Reprod Dev; 2002 Oct; 63(2):168-76. PubMed ID: 12203826
[TBL] [Abstract][Full Text] [Related]
18. T cells are responsive to the simian virus 40 large tumor antigen transgenically expressed in pancreatic islets.
Geiger T; Soldevila G; Flavell RA
J Immunol; 1993 Dec; 151(12):7030-7. PubMed ID: 8258707
[TBL] [Abstract][Full Text] [Related]
19. The SV40 small t-antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice; truncated large T-antigen molecules harboring the intact p53 and pRb binding region do not have this effect.
Goetz F; Tzeng YJ; Guhl E; Merker J; Graessmann M; Graessmann A
Oncogene; 2001 Apr; 20(18):2325-32. PubMed ID: 11402328
[TBL] [Abstract][Full Text] [Related]
20. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R
Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
